Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal

Name: Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
Published: 2009
License: Public Domain

Novartis · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

cardiovascular-disease hypertension

hypertension, abpm, systolic blood pressure, diastolic blood pressure, cardiovascular disease, aliskiren, telmisartan, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal

Related documents